Clinical Trials in Detroit

Showing 17181-17200 of 19,719 trials

Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy

NCT01002950

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of the investigational drug ACU-4429 in subjects with geographic atrophy.

Kubota Vision Inc.72 participantsStarted Oct 2009

Phoenix, Arizona, United States • Beverly Hills, California, United States • Daytona Beach, Florida, United States +9 more locations

COMPLETEDPhase 3< 1 mile

Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis and Chronic Burkholderia Species Infection

NCT01059565

The purpose of this research study was to determine if an experimental drug called Aztreonam for Inhalation Solution (AZLI) was safe and effective to treat Burkholderia lung infections in patients with cystic fibrosis (CF). Spirometry was used to assess pulmonary function, and the revised Cystic Fibrosis Questionnaire (CFQ-R) was used to assess quality of life. The CFQ-R is a validated, patient-reported outcome tool used to measure health-related quality of life for children and adults with CF. The study consisted of a 24-week randomized phase, and a 24-week open-label phase. Primary and secondary efficacy analyses were conducted for the 24-week randomized phase only. Safety data were collected for both the randomized and open-label phases.

Cystic FibrosisBurkholderia Infections

Gilead Sciences102 participantsStarted Feb 2010

Mobile, Alabama, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +32 more locations

Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy

Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis and Chronic Burkholderia Species Infection

Find Trials by Condition in Detroit

Pharmacokinetics of Multiple Ascending Doses of VCH-222 in Subjects With Chronic Hepatitis C Infection

Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite

Ophthalmologic Safety Study of Pramipexole Immediate Release (IR) Versus Ropinirole in Early Parkinson's Disease (PD) Patients

A Comparison of the dermaPACE® (Pulsed Acoustic Cellular Expression) Device in Conjunction With Standard of Care Versus Standard of Care Alone in the Treatment of Diabetic Foot Ulcers

Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations

Initiating Transdermal Estradiol Therapy in Turner's Syndrome

An Efficacy and Safety Study of JNJ-26113100 in the Treatment of Adult Atopic Dermatitis

PEARL-SC Trial: A Study of the Efficacy, Safety, and Tolerability of A 623 Administration in Subjects With Systemic Lupus Erythematosus

Mobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma Patients

Adult Double Cord Blood Transplant Study

STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma

Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN)

Mobilization of Stem Cells With AMD3100 (Plerixafor) and G-CSF in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients

Truvada Versus Truvada Plus Hepatitis B Immunoglobulin (HBIg) in Prevention of Chronic Hepatitis B Recurrence Post Liver Transplant

Adenosine 2A Agonist Lexiscan in Children and Adults With Sickle Cell Disease

Fludarabine (Fludara®) Plus Alemtuzumab (CAMPATH®, MabCampath®) vs Fludarabine Alone in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients

To Compare the Pharmacokinetics of a Single Oral Dose of TC-5214 in Subjects With Renal Impairment and With Subjects With Normal Renal Function

Clinical Trial of the "Living Well With Hearing Loss Workshop"